Диссертация (1139542), страница 57
Текст из файла (страница 57)
‒ 2002. ‒ V. 110, № 4. ‒ P.797-804.Shingo S., Zhang J., Reiss T. F. Correlation of airway obstruction and patient-reportedendpoints in clinical studies. // Eur Respir J. ‒ 2001. ‒ V. 17, № 2. ‒ P. 220-4.Shirai T., Furuhashi K., Suda T., Chida K. Relationship of the asthma control test withpulmonary function and exhaled nitric oxide // Ann Allergy Asthma Immunol. ‒ 2008. ‒ V.101, № 6. ‒ P. 608-613.Shirinbak S., Taher Y. A., Maazi H., al.
e. Suppression of Th2-Driven Airway Inflammationby Allergen Immunotherapy Is Independent of B Cell and Ig Responses in Mice. // J.Immunol. ‒ 2010. ‒ V. 185, № 7. ‒ P. 3857 - 3865.Shult P. A., Graziano F. M., Wallow J. H., Busse W. W. Comparison of superoxidegeneration and luminoldependent chemiluminescence with eosinophils and neutrophils fromnormal individuals. // Lab. Clin.
Med. ‒ 1985. ‒ V. 106, № 6. ‒ P. 638-645.Siddiqui S., Mistry V., Doe C., et al. Airway hyperresponsiveness is dissociated fromairway wall structural remodeling. // J Allergy Clin Immunol. ‒ 2008. ‒ V. 1222. ‒ P. 335341.Sih T., Mion O. Allergic rhinitis in the child and associated comorbidities. // Pediatr AllergyImmunol. ‒ 2010. ‒ V. 21, № 1 Pt 2. ‒ P. 107-113.Silverman M., Anderson S. D., Andrea T. Standardization of Exercise Tests in AsthmaticChildren // Archives of Disease in Childhood. ‒ 1972. ‒ V. 47.
‒ P. 882-889.Simons F. E. Allergic rhinobronchitis: the asthma-allergic rhinitis link. // J Allergy ClinImmunol. ‒ 1999. ‒ V. 104, № 534-540.Simpson J. L., Scott R., Boyle M. J., Gibson P. G. Inflammatory subtypes in asthma:assessment and identification using induced sputum. // Respirology. ‒ 2006. ‒ V. 11, № 1.‒ P. 54-61.Smith A.
D., Cowan J. O., Brassett K. P., Filsell S., McLachlan C., Monti-Sheehan G., PeterHerbison G., Robin Taylor D. Exhaled nitric oxide: a predictor of steroid response // Am JRespir Crit Care Med. ‒ 2005. ‒ V. 172, № 4. ‒ P. 453-459.310456457458459460461462463464465466467468469470471472473474475476477478Spergel J. M., Fogg M. I., Bokszczanin-Knosala A. Correlation of exhaled nitric oxide,spirometry and asthma symptoms // J Asthma. ‒ 2005. ‒ V. 42, № 10. ‒ P. 879-83.Stănciulescu C., Chiru M., Oprea A., Păcurar D., Zăpucioiu C., Petrişor E., Orăşeanu D.The role of FENO and spirometry in the evaluation of obstruction in pediatric asthma. //Pneumologia. - 2015.
‒ P. 40-44.Strunk R. C., Weiss S. T., Yates K. P., al.. e. Mild to moderate asthma affects lung growthin children and adolescents. // J Allergy Clin Immunol. ‒ 2006. ‒ V. 118. ‒ P. 1040-1047.Subbarao P., Mandhane P. J., Sears M. R. Asthma: epidemiology, etiology and risk factors.// CMAJ. ‒ 2009. № 27. ‒ P. 181-190.Szefler S.
J. Advances in pediatric asthma in 2009: Gaining control of childhood asthma //Journal of Allergy and Clinical Immunology. ‒ 2009. ‒ V. 125, № 1. ‒ P. 69-78.Szefler S. J., Wenzel S., Brown R., Erzurum S. C., al. E. Asthma outcomes: biomarkers. // JAllergy Clin Immunol. ‒ 2012. ‒ V. 129, № 3 Suppl. ‒ P. 9-23.Takara G. N., Ruas G., Pessoa B. V., al. e. Comparison of five portable peak flow meters. //Clinics (Sao Paulo). ‒ 2010.
‒ V. 65, № 5. ‒ P. 469-474.Tam A., Wadsworth S., Dorscheid D., Man S. F., Sin D. D. The airway epithelium: morethan just a structural barrier // Ther Adv Respir Dis. ‒ 2011. ‒ V. 5, № 4. ‒ P. 255-273.Taylor D. R. Nitric oxide as a clinical guide for asthma management // J Allergy ClinImmunol. ‒ 2006. ‒ V. 117, № 2. ‒ P. 259-262.Taylor D. R., Bateman E. D., Boulet L. P., al. e.
A new perspective on concepts of asthmaseverity and control. // Eur Respir J. ‒ 2008. ‒ V. 32, № 3. ‒ P. 545-554.Tekin D., Ayse Sin B., Mungan D., Misirligil Z., S. Y. The antioxidant defense in asthma. //J Asthma. ‒ 2000. ‒ V. 37. ‒ P. 59-63.Thayer J. F., Loerbroks A., Sternberg E. M. Inflammation and cardiorespiratory control: therole of the vagus nerve. // Respir Physiol Neurobiol. ‒ 2011. ‒ V. 178. ‒ P.
387-394.Thomson N. C. Novel approaches to the management of noneosinophilic asthma. // TherAdv Respir Dis. 2016. – pii: 1753465816632638.Thory O., Kitagawa M., Masayki M. Attenuation of the bactericidal activity of neutrophilby oxidized lipoproteins. // Med. biochem. and chem. aspects free radicals. ‒ Amsterdam,1988. ‒ C. 1343-1346.Tierney W. M., Roenser J. F., SesHardi R., al. E. assesing symptoms and peak expiratoryflow rate s predictors asthma exacerbations. // J Gentlern Med. ‒ 2004. ‒ V. 19.
‒ P. 237242.Tokuyama K., Morikawa A., al. е. Beat-to-beat variation of the heart rate in children withallergic asthma. // J. Asthma ‒ 1985. ‒ V. 22 №6 ‒ P. 285-288.Tomasiak-Lozowska M. M., Zietkowski Z., Przeslaw K., Tomasiak M., al. e. Inflammatorymarkers and acidbase equilibrium in exhaled breath condensate of stable and unstableasthma patients. // Int Arch Allergy Immunol. - 2012. ‒ V. 159. - P. 121-129.Tosca M.
A., Riccio A. M., Marseglia G. L., Caligo G., al. E. Nasal endoscopy in asthmaticchildren: assessment of rhinosinusitis and adenoiditis incidence, correlations with cytologyand microbiology. // Clin Exp Allergy. ‒ 2001. ‒ V. 31, № 4. ‒ P. 609-615.Undem B. J., Kollarik M. The Role of Vagal Afferent Nerves in Chronic ObstructivePulmonary Disease. // The Role of Vagal Afferent Nerves in Chronic ObstructivePulmonary Disease.
/ 2005. ‒ C. 355-360.Undem B. J., McAlexander M., Hunter D. D. Neurobiology of the upper and lower airways.// Allergy. ‒ 1999. ‒ V. 54, № Suppl 57. ‒ P. 81-93.Upham J. W., James A. L. Remission of asthma: The next therapeutic frontier? // PharmacolTher. ‒ 2011. ‒ V. 130, № 1. ‒ P. 38-45.Van Cauwenberge P., Sys L., De Belder T., Watelet J. B. Anatomy and physiology of thenose and the paranasal sinuses. // Immunol Allergy Clin N Am. ‒ 2004 №24. ‒ P.
1-17.van de Kant K., Klaassen E., Jöbsis Q., Nijhuis A., al. E. Early diagnosis of asthma inyoung children by using non-invasive biomarkers of airway inflammation and early lung311479480481482483484485486487488489490491492493494495496497function measurements: study protocol of a case-control study. // BMC Public Health. ‒2009. № 9. ‒ P.
210-222.van den Berge M., ten Hacken N. H., Cohen J., Douma W. R., Postma D. S. Small airwaydisease in asthma and COPD: clinical implications. // Chest. ‒ 2011. ‒ V. 139, № 2. ‒ P.412-23.van Den Toorn L. M., Prins J. B., Overbeek S. E., Hoogsteden H. C., de Jongste J.
C.Adolescents in clinical remission of atopic asthma have elevated exhaled nitric oxide levelsand bronchial hyperresponsiveness // Am J Respir Crit Care Med. ‒ 2000. ‒ V. 162, № 3 Pt1. ‒ P. 953-957.van der Velden V. H., Hulsmann A. R. Autonomic innervation of human airways: structure,function, and pathophysiology in asthma // Neuroimmunomodulation. ‒ 1999. ‒ V.
6, № 3.‒ P. 145-59.van Vliet D., Alonso A., Rijkers G. T., et al. Prediction of asthma exacerbations in childrenby innovative exhaled inflammatory markers: results of a longitudinal study. // PLoS One. ‒2015. ‒ V. 10, № 3. doi: 10.1371/journal.pone.0119434Vandenplas O., Dramaix M., Joos G., al.
e. The impact of concomitant rhinitis on asthmarelated quality of life and asthma control. // Allergy. ‒ 2010. ‒ V. 65. ‒ P. 1290-1297.Vargas L., Patino P. J., Montoya F., Vanegas A. C., Eschavarria A., Garcia de Olarte D. Astudi of granulocyte respiratory burst in patient with allergic bronchial asthma. //Inflammation.
‒ 1998. ‒ V. 22. ‒ P. 45-54.Vaughan J., Ngamtrakulpanit L., Pajewski T. N., Turner R., al. e. Exhaled breathcondensate pH is a robust and reproducible assay of airway acidity. // Eur Respir J. - 2003. ‒V. 22. - P. 889-894.Wadsworth S., Sin D., Dorscheid D.
Clinical update on the use of biomarkers of airwayinflammation in the management of asthma. // J Asthma Allergy. ‒ 2011. № 4. ‒ P. 77-86.Wagner E. M., Liu M. C., Weinmann G. G., Permutt S., Bleecker E. R. Peripheral lungresistance in normal and asthmatic subjects. // Am Rev Respir Dis. ‒ 1990. № 141. ‒ P. 584588.Waibel V., Ulmer H., Horak E. Assessing asthma control: symptom scores, GINA levels ofasthma control, lung function, and exhaled nitric oxide.
// Pediatr Pulmonol. ‒ 2012 ‒V. 47,№ 2. ‒ P. 113-118.Wechsler M. E. Getting control of uncontrolled asthma. // Am J Med. ‒ 2014. ‒ V. 127, №11. ‒ P. 1049-1059.Wedes S. H., Khatri S. B., Zhang R., Wu W., Comhair S. A., Wenzel S., Teague W. G.,Israel E., Erzurum S. C., Hazen S. L. Noninvasive markers of airway inflammation inasthma. // Clin Transl Sci. ‒ 2009. ‒ V. 2, № 2. ‒ P. 112-117.Weir T. D., Mallek N. O. A., al. e.
beta 2-Adrenergic Receptor Haplotypes in Mild,Moderate and Fatal/Near Fatal Asthma. // Am. J. Resp. Crit. Care Med. ‒ 1998. ‒ V. 158, №3. ‒ P. 787-791.Wenzel S. E. Asthma phenotypes: the evolution from clinical to molecular approaches. //Nat. Med. . ‒ 2012. ‒ V. 18. ‒ P. 716-725.Whyte K. F., Douglas N. J. Posture and nocturnal asthma. // Thorax ‒1989. ‒ V.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
